阿皮基宁对动脉样硬化的亡指数的影响
Zhuo-Nan Jia1,2, Bo-Yu Zhang1,2, Zhi-Yuan Gao1,2
1Basic Medical College of Chengde Medical University, Chengde 067000, Hebei, China.
Journal of cardiovascular pharmacology
|August 7, 2025
概括
在老鼠中,阿皮珍因有效降低血脂,并通过降低LOX-1表达和增加Bcl-2/Bax比率来减少动脉样硬化. 这项研究支持阿比基尼尼.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化是一种复杂的心血管疾病,其机制不完全理解.
- 作为一种天然的黄类化合物,apigenin对抗动脉样硬化的效果有前途,需要进一步的机械研究.
研究的目的:
- 在大鼠模型中研究阿皮基宁对动脉样硬化的作用.
- 为了评估LOX-1,Bcl-2和Bax基因在对阿皮基因治疗的反应中的表达.
- 探索这些基因在apigenin抗动脉样硬化机制中的作用.
主要方法:
- 生物信息学分析以确定与动脉样硬化的基因关系.
- 在动物实验中,使用治疗了apigenin的动脉样硬化大鼠.
- 使用自动化分析仪进行血脂水平分析.
- 西方斑点测试用于LOX-1蛋白质检测.
- 用RT-qPCR对Bcl-2和BaxmRNA进行量化.
主要成果:
- 在老鼠中,阿皮基宁治疗显著降低了血脂水平.
- 原蛋白的使用降低了LOX-1的表达 (类似莱克的氧化LDL受体-1).
- 阿皮基宁治疗增加了Bcl-2/Bax比率,表明了抗亡作用.
结论:
- 在老鼠中,阿皮根因在降低血脂和减轻动脉样硬化进展方面表现出有效性.
- 原蛋白的抗动脉样硬化作用与LOX-1表达的减少和阿波性基因表达的调节有关 (Bcl-2/Bax比).
- 这些发现为开发apigenin作为动脉样硬化的治疗剂提供了科学基础.
相关概念视频
01:30Apoptosis
12.0K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K
01:31The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:30Atherosclerosis I: Introduction
85
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
85
01:17The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
01:17Phagocytosis of Apoptotic Cells
4.0K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
4.0K